Chinese Herbal Medicine in the Treatment of Chronic Heart Failure: Three-Stage Study Protocol for a Randomized Controlled Trial

Liangtao Luo, Jianxin Chen, Shuzhen Guo, Juan Wang, Kuo Gao, Peng Zhang, Chan Chen, Huihui Zhao, Wei Wang, Liangtao Luo, Jianxin Chen, Shuzhen Guo, Juan Wang, Kuo Gao, Peng Zhang, Chan Chen, Huihui Zhao, Wei Wang

Abstract

Background. Chinese herbal medicine (CHM) has been used in the treatment of chronic heart failure (CHF) for a long time. Treatment based on syndrome differentiation and the main characteristic of TCM is the fundamental principle of TCM practice. In this study protocol, we have designed a trial to assess the efficacy and safety of CHM on CHF based on syndrome differentiation. Methods/Design. This is a three-stage trial of CHM in the treatment of CHF. The first stage is a literature review aiming to explore the common syndromes of CHF. The second is a multicentral, randomized, placebo-controlled trial to evaluate the efficacy and safety of CHM for the treatment of CHF. The third is a multicentral, randomized controlled clinical trial aiming to make cost-effectiveness analysis and evaluate the feasibility, compliance, and universality of CHM on CHF. Discussion. This trial will evaluate the efficacy, safety, feasibility, compliance, and universality of CHM on CHF. The expected outcome is to provide evidence-based recommendations for CHM on CHF and develop a prescription of CHM in the treatment of CHF. This trial is registered with NCT01939236 (Stage Two of the whole trial).

Figures

Figure 1
Figure 1
The flowchart of Stage One trial design.
Figure 2
Figure 2
The flowchart of Stage Two trial design.
Figure 3
Figure 3
The flowchart of Stage Three trial design.

References

    1. Dickstein K., Cohen-Solal A., Filippatos G., et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) European Journal of Heart Failure. 2008;10:933–989. doi: 10.1016/j.ejheart.2008.08.005.
    1. Gu D. F., Huang G. Y., He J., et al. Investigation of prevalence and distributing feature of chronic heart failure in Chinese adult population. Chinese Journal of Cardiology. 2003;1:3–6.
    1. Roger V. L., Go A. S., Lloyd-Jones D. M., et al. Heart disease and stroke statistics—2012 update: a report from the American Heart Association. Circulation. 2012;125(1):e2–e220. doi: 10.1161/cir.0b013e31823ac046.
    1. National Institutes of Health. Morbidity & Mortality: 2012 Chart Book on Cardiovascular, Lung, and Blood Diseases. 2012.
    1. Chinese Society of Cardiology of Chinese Medical Association. Guidelines for the diagnosis and management of chronic heart failure. Chinese Journal of Cardiology. 2007;12:1076–1095.
    1. Yancy C. W., Jessup M., Bozkurt B., et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American college of cardiology foundation/american heart association task force on practice guidelines. Journal of the American College of Cardiology. 2013;62(16):e147–e239. doi: 10.1016/j.jacc.2013.05.019.
    1. Wu Y. L., Gu C. H., Xu G. C., Wei C., Gao X. D. Clinical observation of randomized double-blind and multicenter trial on Qiliqiangxin capsule in the treatment of chronic heart failure. Chinese Journal of Difficult and Complicated Cases. 2007;5:263–266.
    1. Hou Y.-Z., Mao J.-Y., Wang X.-L., Li J., Liu C.-X. Shenfu injection for patients with heart failure: a systematic review. Chinese Journal of Evidence-Based Medicine. 2011;11(3):292–299.
    1. Hou Y. Z., Mao J. Y., Wang X. L., Liu C. X., Zhang C. Shenmai injection in heart failure patients: a systematic review and meta-analysis. Chinese Journal of Evidence-Based Medicine. 2010;10(8):939–945.
    1. Peng Z. Study of Distribution Regularities of Common Traditional Chinese Medicine Syndromes and Syndrome Factors in Patients with Chronic Heart Failure Caused by Coronary Heart Disease. Beijing, China: Beijing University of Chinese Medicine; 2011.
    1. Association NYH. Diseases of the Heart and Blood Vessels: Nomenclature and Criteria for Diagnosis. Little, Brown; 1964.
    1. Zheng X. Y. The Guiding Principles for the Clinical Study of New Drugs for Use in Traditional Chinese Medicine (In Trying) Chinese Medical Science and Technology Press; 2002.
    1. Li X., Zhang J., Huang J., et al. A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure. Journal of the American College of Cardiology. 2013;62(12):1065–1072. doi: 10.1016/j.jacc.2013.05.035.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj